REPORT ID 551

Global Secondary Antibodies Sales Market Report 2017

Publish Date
04-Dec-17
Pages
122
Format
Electronic (PDF)

In this report, the global Secondary Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Secondary Antibodies for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Secondary Antibodies market competition by top manufacturers/players, with Secondary Antibodies sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific (US)
    Jackson ImmunoResearch Laboratories (US)
    BD Biosciences (US)
    Santa Cruz Biotechnology (US)
    GE Healthcare (US)
    Sigma-Aldrich (US)
    Dako (US)
    LI-COR Biosciences (US)
    SouthernBiotech (US)
    Vector Laboratories (US)
    Bio-Rad (US)
    eBioscience (US)
    Cell Signaling Technology (US)
    Dianova (Germany)
    Abcam (UK)
    EMD Millipore (US)
    R&D Systems (US)
    Rockland Immunochemicals (US)
    Bethyl (US)
    Kirkegaard & Perry Laboratories (US)
    BioLegend (US)
    Abbexa (UK)
    Biorbyt (UK)
    Acris Antibodies (Germany)
    BioLogo (Germany)
    Sino Biological (China)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Men'
    Animals'
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    ELISA (Including Many HIV Tests)
    Western Blot
    Immunostaining
    Immunohistochemistry
    Immunocytochemistry

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Secondary Antibodies Sales Market Report 2017
1 Secondary Antibodies Market Overview
    1.1 Product Overview and Scope of Secondary Antibodies
    1.2 Classification of Secondary Antibodies by Product Category
        1.2.1 Global Secondary Antibodies Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Secondary Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Men'
        1.2.4 Animals'
    1.3 Global Secondary Antibodies Market by Application/End Users
        1.3.1 Global Secondary Antibodies Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 ELISA (Including Many HIV Tests)
        1.3.3 Western Blot
        1.3.4 Immunostaining
        1.3.5 Immunohistochemistry
        1.3.6 Immunocytochemistry
    1.4 Global Secondary Antibodies Market by Region
        1.4.1 Global Secondary Antibodies Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Secondary Antibodies Status and Prospect (2012-2022)
        1.4.3 China Secondary Antibodies Status and Prospect (2012-2022)
        1.4.4 Europe Secondary Antibodies Status and Prospect (2012-2022)
        1.4.5 Japan Secondary Antibodies Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Secondary Antibodies Status and Prospect (2012-2022)
        1.4.7 India Secondary Antibodies Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Secondary Antibodies (2012-2022)
        1.5.1 Global Secondary Antibodies Sales and Growth Rate (2012-2022)
        1.5.2 Global Secondary Antibodies Revenue and Growth Rate (2012-2022)

2 Global Secondary Antibodies Competition by Players/Suppliers, Type and Application
     2.1 Global Secondary Antibodies Market Competition by Players/Suppliers
        2.1.1 Global Secondary Antibodies Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Secondary Antibodies Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Secondary Antibodies (Volume and Value) by Type
        2.2.1 Global Secondary Antibodies Sales and Market Share by Type (2012-2017)
        2.2.2 Global Secondary Antibodies Revenue and Market Share by Type (2012-2017)
    2.3 Global Secondary Antibodies (Volume and Value) by Region
        2.3.1 Global Secondary Antibodies Sales and Market Share by Region (2012-2017)
        2.3.2 Global Secondary Antibodies Revenue and Market Share by Region (2012-2017)
    2.4 Global Secondary Antibodies (Volume) by Application

3 United States Secondary Antibodies (Volume, Value and Sales Price)
    3.1 United States Secondary Antibodies Sales and Value (2012-2017)
        3.1.1 United States Secondary Antibodies Sales and Growth Rate (2012-2017)
        3.1.2 United States Secondary Antibodies Revenue and Growth Rate (2012-2017)
        3.1.3 United States Secondary Antibodies Sales Price Trend (2012-2017)
    3.2 United States Secondary Antibodies Sales Volume and Market Share by Players
    3.3 United States Secondary Antibodies Sales Volume and Market Share by Type
    3.4 United States Secondary Antibodies Sales Volume and Market Share by Application

4 China Secondary Antibodies (Volume, Value and Sales Price)
    4.1 China Secondary Antibodies Sales and Value (2012-2017)
        4.1.1 China Secondary Antibodies Sales and Growth Rate (2012-2017)
        4.1.2 China Secondary Antibodies Revenue and Growth Rate (2012-2017)
        4.1.3 China Secondary Antibodies Sales Price Trend (2012-2017)
    4.2 China Secondary Antibodies Sales Volume and Market Share by Players
    4.3 China Secondary Antibodies Sales Volume and Market Share by Type
    4.4 China Secondary Antibodies Sales Volume and Market Share by Application

5 Europe Secondary Antibodies (Volume, Value and Sales Price)
    5.1 Europe Secondary Antibodies Sales and Value (2012-2017)
        5.1.1 Europe Secondary Antibodies Sales and Growth Rate (2012-2017)
        5.1.2 Europe Secondary Antibodies Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Secondary Antibodies Sales Price Trend (2012-2017)
    5.2 Europe Secondary Antibodies Sales Volume and Market Share by Players
    5.3 Europe Secondary Antibodies Sales Volume and Market Share by Type
    5.4 Europe Secondary Antibodies Sales Volume and Market Share by Application

6 Japan Secondary Antibodies (Volume, Value and Sales Price)
    6.1 Japan Secondary Antibodies Sales and Value (2012-2017)
        6.1.1 Japan Secondary Antibodies Sales and Growth Rate (2012-2017)
        6.1.2 Japan Secondary Antibodies Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Secondary Antibodies Sales Price Trend (2012-2017)
    6.2 Japan Secondary Antibodies Sales Volume and Market Share by Players
    6.3 Japan Secondary Antibodies Sales Volume and Market Share by Type
    6.4 Japan Secondary Antibodies Sales Volume and Market Share by Application

7 Southeast Asia Secondary Antibodies (Volume, Value and Sales Price)
    7.1 Southeast Asia Secondary Antibodies Sales and Value (2012-2017)
        7.1.1 Southeast Asia Secondary Antibodies Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Secondary Antibodies Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Secondary Antibodies Sales Price Trend (2012-2017)
    7.2 Southeast Asia Secondary Antibodies Sales Volume and Market Share by Players
    7.3 Southeast Asia Secondary Antibodies Sales Volume and Market Share by Type
    7.4 Southeast Asia Secondary Antibodies Sales Volume and Market Share by Application

8 India Secondary Antibodies (Volume, Value and Sales Price)
    8.1 India Secondary Antibodies Sales and Value (2012-2017)
        8.1.1 India Secondary Antibodies Sales and Growth Rate (2012-2017)
        8.1.2 India Secondary Antibodies Revenue and Growth Rate (2012-2017)
        8.1.3 India Secondary Antibodies Sales Price Trend (2012-2017)
    8.2 India Secondary Antibodies Sales Volume and Market Share by Players
    8.3 India Secondary Antibodies Sales Volume and Market Share by Type
    8.4 India Secondary Antibodies Sales Volume and Market Share by Application

9 Global Secondary Antibodies Players/Suppliers Profiles and Sales Data
    9.1 Thermo Fisher Scientific (US)
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Secondary Antibodies Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Thermo Fisher Scientific (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Jackson ImmunoResearch Laboratories (US)
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Secondary Antibodies Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 BD Biosciences (US)
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Secondary Antibodies Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 BD Biosciences (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Santa Cruz Biotechnology (US)
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Secondary Antibodies Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Santa Cruz Biotechnology (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 GE Healthcare (US)
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Secondary Antibodies Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 GE Healthcare (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Sigma-Aldrich (US)
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Secondary Antibodies Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Sigma-Aldrich (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Dako (US)
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Secondary Antibodies Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Dako (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 LI-COR Biosciences (US)
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Secondary Antibodies Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 LI-COR Biosciences (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 SouthernBiotech (US)
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Secondary Antibodies Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 SouthernBiotech (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Vector Laboratories (US)
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Secondary Antibodies Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Vector Laboratories (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Bio-Rad (US)
    9.12 eBioscience (US)
    9.13 Cell Signaling Technology (US)
    9.14 Dianova (Germany)
    9.15 Abcam (UK)
    9.16 EMD Millipore (US)
    9.17 R&D Systems (US)
    9.18 Rockland Immunochemicals (US)
    9.19 Bethyl (US)
    9.20 Kirkegaard & Perry Laboratories (US)
    9.21 BioLegend (US)
    9.22 Abbexa (UK)
    9.23 Biorbyt (UK)
    9.24 Acris Antibodies (Germany)
    9.25 BioLogo (Germany)
    9.26 Sino Biological (China)

10 Secondary Antibodies Maufacturing Cost Analysis
    10.1 Secondary Antibodies Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Secondary Antibodies
    10.3 Manufacturing Process Analysis of Secondary Antibodies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Secondary Antibodies Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Secondary Antibodies Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Secondary Antibodies Market Forecast (2017-2022)
    14.1 Global Secondary Antibodies Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Secondary Antibodies Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Secondary Antibodies Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Secondary Antibodies Price and Trend Forecast (2017-2022)
    14.2 Global Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Secondary Antibodies Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Secondary Antibodies Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Secondary Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Secondary Antibodies Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Secondary Antibodies Sales Forecast by Type (2017-2022)
       14.3.2 Global Secondary Antibodies Revenue Forecast by Type (2017-2022)
       14.3.3 Global Secondary Antibodies Price Forecast by Type (2017-2022)
    14.4 Global Secondary Antibodies Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer